Finance

Beta
Lists
2511:HKG
HighTide Therapeutics Inc
HK$2.73
-2.50%
(-0.070) 1D
Jun 9, 4:08:11 PM GMT+8  ·   HKD
All symbols
SymbolPriceChange% Change
Generating top insights for 2511...
Open
HK$2.80
High
HK$2.81
Low
HK$2.73
Mkt. cap
1.56B
Avg. vol.
778.45K
Volume
376.00K
52-wk high
HK$4.72
52-wk low
HK$1.80
EPS
-HK$0.59
Shares outstanding
571.33M
No. of employees
51
Open
HK$2.80
High
HK$2.81
Low
HK$2.73
Mkt. cap
1.56B
Avg. vol.
778.45K
Volume
376.00K
52-wk high
HK$4.72
52-wk low
HK$1.80
EPS
-HK$0.59
Shares outstanding
571.33M
No. of employees
51
Analyst outlook
Analyst Ratings
Based on 1 analyst giving stock ratings to 2511 in the past 3 months
Buy
Buy
1
Hold
0
Sell
0
12 month forecast
Based on 1 Wall Street analyst offering 12 month price targets for 2511 in the last 3 months.
Highest
Current HK$2.73
HK$5.80 (+112.45%)
Average
HK$5.80 (+112.45%)
Lowest
HK$5.80 (+112.45%)
News stories
From sources across the web
About HighTide Therapeutics Inc
CEO-
Employees51
Founded2011
Headquarters-
SectorBiotechnology
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
53.21M
53.21M
29.03M
29.03M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
10.81M
10.81M
18.74M
18.74M
Operating expense
64.02M
64.02M
47.77M
47.77M
Total operating expenses
64.02M
64.02M
47.77M
47.77M
Operating income
-64.02M
-64.02M
-47.77M
-47.77M
Other non operating income
2.47M
2.47M
1.79M
1.79M
EBT including unusual items
-56.93M
-56.93M
-59.02M
-59.02M
EBT excluding unusual items
-59.84M
-59.84M
-43.65M
-43.65M
Income tax expense
3.00K
3.00K
106.50K
106.50K
Effective tax rate
-0.01%
-0.01%
-0.18%
-0.18%
Other operating expenses
-
-
-
-
Net income
-60.16M
-60.16M
-62.33M
-62.33M
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
2.78M
2.78M
2.47M
2.47M
Interest expense
-788.00K
-788.00K
-394.00K
-394.00K
Net interest expenses
2.00M
2.00M
2.07M
2.07M
Depreciation and amortization charges
-
-
-
-
EBITDA
-63.64M
-63.64M
-47.44M
-47.44M
Gain or loss from assets sale
19.50K
19.50K
3.00K
3.00K
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more